1. IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella
   Qiubin Lin et al, 2021, Nature Communications CrossRef
2. Salmonella enterica and outer membrane vesicles are current and future options for cancer treatment
   Genesy Pérez Jorge et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
3. Salmonella Typhimurium as an Anticancer Therapy: Recent Advances and Perspectives
   Katherine M. Broadway et al, 2019, Current Clinical Microbiology Reports CrossRef
4. Attenuated mutants of Salmonella enterica Typhimurium mediate melanoma regression via an immune response
   Genesy Pérez Jorge et al, 2024, Experimental Biology and Medicine CrossRef
5. Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
   Ding Wang et al, 2021, Frontiers in Immunology CrossRef
6. Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009
   Katherine M. Broadway et al, 2017, Journal of Biotechnology CrossRef
7. Inhibition of acute leukemia with attenuated Salmonella typhimurium strain VNP20009
   Meirong Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
8. Engineering the gut microbiome
   Xiaowu Bai et al, 2023, Nature Reviews Bioengineering CrossRef
9. miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1
   Zhuojia Lin et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
10. Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivo
    Jiawen Chen et al, 2023, Journal of Neuro-Oncology CrossRef
11. Integration of Salmonella into Combination Cancer Therapy
    Besan H. Al-Saafeen et al, 2021, Cancers CrossRef
12. Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium
    Yanxia Guo et al, 2020, Cancer Letters CrossRef
13. Targeted IFNγ induction by a genetically engineered Salmonella typhimurium is the key to the liver metastasis inhibition in a mouse model of pancreatic neuroendocrine tumor
    Zhan Hua et al, 2023, Frontiers in Medicine CrossRef
14. Bacteria-Based Nanoprobes for Cancer Therapy
    Yiping Lu et al, 2024, International Journal of Nanomedicine CrossRef
15. Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy
    Kang Liang et al, 2019, Cancer Letters CrossRef
16. Genetically engineered bacterium: Principles, practices, and prospects
    Yiting Liu et al, 2022, Frontiers in Microbiology CrossRef
17. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy
    Jiawen Chen et al, 2022, Biomedicine & Pharmacotherapy CrossRef
18. Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”
    Xiangcheng Zhao et al, 2023, Pharmaceutics CrossRef
19. Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression
    Li-Wen Shen et al, 2020, Scientific Reports CrossRef
20. Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer Salmonella
    Shuxin Yang et al, 2021, Frontiers in Immunology CrossRef